Abstract
Pre-clinical quantitative imaging endpoints have been challenging in mouse models of cerebrovascular disease. Here we present optical coherence imaging platforms that can quantify blood flow, capillary perfusion, cellular status, and oxygen extraction based on intrinsic scattering signatures.
| Original language | English (US) |
|---|---|
| Title of host publication | CLEO |
| Subtitle of host publication | Applications and Technology, CLEO_AT 2014 |
| Publisher | Optical Society of American (OSA) |
| ISBN (Print) | 9781557529992 |
| State | Published - Jan 1 2014 |
| Event | CLEO: Applications and Technology, CLEO_AT 2014 - San Jose, CA, United States Duration: Jun 8 2014 → Jun 13 2014 |
Other
| Other | CLEO: Applications and Technology, CLEO_AT 2014 |
|---|---|
| Country | United States |
| City | San Jose, CA |
| Period | 6/8/14 → 6/13/14 |
ASJC Scopus subject areas
- Instrumentation
- Atomic and Molecular Physics, and Optics
Fingerprint Dive into the research topics of 'Optical coherence imaging of hemodynamics, metabolism, and cell viability during brain injury'. Together they form a unique fingerprint.
Cite this
Srinivasan, V., Chong, S. P., Merkle, C. W., Radhakrishnan, H., & Leahy, C. (2014). Optical coherence imaging of hemodynamics, metabolism, and cell viability during brain injury. In CLEO: Applications and Technology, CLEO_AT 2014 Optical Society of American (OSA).